Dystrogen Therapeutics

Dystrogen Therapeutics is a clinical-stage life sciences company dedicated to developing personalized therapies for rare genetic disorders and also a clinical-stage chimeric cell therapy company focused on rare diseases. The company is currently testing Dystrophin Expressing Chimeric (DEC) cell therapy for Duchenne Muscular Dystrophy.